Evaluation of a SARS-CoV-2 surrogate virus neutralization test for detection of antibody in human, canine, cat, and hamster sera.

Background: Hong Kong was one of the first locations outside of mainland China to identify COVID-19 cases in January 2020. We assessed the impact of various public health measures on transmission.Methods: We analysed data on all COVID-19 cases and public health measures in Hong Kong up to 7 May 2020. We described case-based, travel-based and community-based measures and examined their potential effects on case identification and transmission. Changes in transmissibility measured by the effective reproductive number Rt were estimated by comparing the Rt between periods when public health measures were and were not in effect. Delays in case confirmation in imported cases and locally infected cases were analysed to indicate the possible impact of expansion of laboratory testing capacity.Findings: Introduction of a 14-day quarantine on persons arriving from affected areas was associated with a 95% reduction in transmissibility from imported cases. Testing all arriving travelers reduced mean delays between arrival and detection of imported cases. Increases in laboratory testing capacity for pneumonia inpatients and symptomatic outpatients reduced the delay from onset to confirmation. Working from home and physical distancing measures implemented in high-risk facilities were associated with 67% and 58% reductions in transmission of COVID-19, respectively.Interpretation: Suppression of COVID-19 transmission in the first pandemic wave in Hong Kong was achieved through integration of travel-based, case-based and community-based public health measures focusing on early case identification and isolation and physical distancing.

No abstract

The resistance proportions and prevalence of MRSA infections in the Asia Pacific is comparable to those reported in other regions with no significant secular changes in the past decade. Country income status and the characteristics of the sample population explained more variations in the reported resistance proportions and prevalence of MRSA than methodological differences in AST across locations in the Region.

Given global Coronavirus Disease 2019 (COVID-19) vaccine shortages and inequity of vaccine distributions, fractionation of vaccine doses might be an effective strategy for reducing public health and economic burden, notwithstanding the emergence of new variants of concern. In this study, we developed a multi-scale model incorporating population-level transmission and individual-level vaccination to estimate the costs of hospitalization and vaccination and the economic benefits of reducing COVID-19 deaths due to dose-fractionation strategies in India. We used large-scale survey data of the willingness to pay together with data of vaccine and hospital admission costs to build the model. We found that fractional doses of vaccines could be an economically viable vaccination strategy compared to alternatives of either full-dose vaccination or no vaccination. Dose-sparing strategies could save a large number of lives, even with the emergence of new variants with higher transmissibility.